EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors

Emilia L Bialek, Roos Buds, Ingrid Dijkgraaf, Pedro E Marques iD

Basic & Clinical Pharmacology & Toxicology · 2026-10 · 139 (4)

DOI: 10.1111/bcpt.70281 ↗

At a glance

Übersichtsarbeit in Basic & Clinical Pharmacology & Toxicology, published online on 2026-09-10. Written by Emilia L Bialek and 3 co-authors. Institution: Laboratory of Molecular Immunology, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium. Major MEDLINE topics: Chemokines, Inflammation, Ticks. 92 references. The full text is freely available in PubMed Central. Funded by: Fonds Wetenschappelijk Onderzoek, KU Leuven, Global PhD Partnerships between KU Leuven and Maastricht University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Ticks are haematophagous parasites that rely on uninterrupted bloodmeals for survival and need an effective strategy to suppress the host inflammatory response. Leukocyte recruitment is a chemokine‐mediated hallmark of inflammation, which ticks counteract via anti‐chemokine proteins in their saliva named evasins. They are a heterogeneous family of glycoproteins that redundantly bind and inhibit chemokines. We provide a detailed overview of their chemokine‐binding properties, as well as their therapeutic efficacy in models of inflammation in vivo. Moreover, we discuss the potential challenges posed by using evasins in a therapeutic setting and explore how the development of modified evasins might aid this.

Subjects

MeSH terms (MEDLINE)

ChemokinesInflammationTicksAnimalsHumansAnti-Inflammatory Agents

Substances

ChemokinesAnti-Inflammatory Agents

Authors and institutions

  • Laboratory of Molecular Immunology, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Department of Biochemistry (CARIM), Maastricht University, Maastricht, the Netherlands.
  • Department of Radiology and Nuclear Medicine, Maastricht UMC+, Maastricht, the Netherlands.

ORCID profiles: Pedro E Marques

Funding

  • Fonds Wetenschappelijk Onderzoek
  • KU Leuven
  • Global PhD Partnerships between KU Leuven and Maastricht University

Cite

APA

Bialek, E. L., Buds, R., Dijkgraaf, I., & Marques, P. E. (2026). Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors. Basic & Clinical Pharmacology & Toxicology, 139(4). https://doi.org/10.1111/bcpt.70281

Vancouver

Bialek EL, Buds R, Dijkgraaf I, Marques PE. Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors. Basic & Clinical Pharmacology & Toxicology. 2026;139(4). doi:10.1111/bcpt.70281

BibTeX
@article{Bialek2026,
  author = {Bialek, Emilia L and Buds, Roos and Dijkgraaf, Ingrid and Marques, Pedro E},
  title = {Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  volume = {139},
  number = {4},
  doi = {10.1111/bcpt.70281}
}
Start for free →